Fundraising Fox

Adam E. Fine

Investor

General Partner & CEO at Windham Capital Partners · Board director at Valera Health · Board director at RxWare · Board director at GlySens

New York, New York, United States

About

Co-founder, General Partner and CEO of Windham Capital Partners, currently a board director at RxWare, Neuspera, Andros and Valera. Previously VP & GM at healthcare enterprise software company I-many, and earlier worked at Johnson & Johnson companies Cordis & Biosense and at Coopers & Lybrand.

Contact· self-published, not guessed

Invests in

BiotechDeep TechHardwareHealthtechSaaS

Board director at Valera Health

Intro paths

→

In turn, Adam can intro founders to Valera Health's investors below.

Valera Health's investors · 9

Atlantic Vantage PointParis · $1M – $150M checksAXA Venture PartnersNew YorkConnecticut InnovationsNew Haven · $500K – $2M checksCorewell Health VenturesGrand RapidsCU Healthcare Innovation FundAuroraFigure 8 InvestmentsWestern North Carolina · $50K – $500K checksGreyMatterBerkeleyMedStartr VenturesNew YorkWindham Capital PartnersNew York · $1M – $5M checks

Co-founders at Valera Health

TT
Thomas TsangExecutive Officer, Director
DT
Dr. Thomas Tsang

Board director at RxWare

Intro paths

→

In turn, Adam can intro founders to RxWare's investors below.

RxWare's investors · 3

Vodia VenturesNew YorkWindham Capital PartnersNew York · $1M – $5M checksZORATel Aviv

Board director at GlySens

Intro paths

→

In turn, Adam can intro founders to GlySens's investors below.

GlySens's investors · 1

Windham Capital PartnersNew York · $1M – $5M checks · since 2015

Co-founders at GlySens

JY
JOSEPH Y. LUCISANOCHIEF TECHNOLOGY OFFICER

Experience

  1. Windham Capital PartnersFounder & Managing Partnercurrent2006 — present
  2. ChromaCode, Inc.Board Observercurrent2019 — present
  3. Upward Health (formerly BehaveCare)Board Observercurrent2017 — present
  4. androsBoard Membercurrent2017 — presentGreater New York City Area
  5. NeuSpera Medical Inc.Board Membercurrent2017 — presentSan Jose, California
  6. Personal Genome DiagnosticsBoard Observercurrent2015 — present
  7. CureatrBoard Observercurrent2015 — present
  8. Cartiva, Inc.Board Observercurrent2015 — present
  9. VytronUSBoard Observercurrent2014 — present
  10. NUVAIRA, Inc.Board Observercurrent2014 — present
  11. GlySens, Inc.Board Membercurrent2009 — present
  12. CoravinDirector2015 — 2016
  13. I-many, Inc.VP & General Manager, Life Sciences2001 — 2005
  14. Cordis, Johnson & JohnsonAnalyst, Business Development1998 — 2001
  15. Coopers & LynbrandAnalyst, Integrated Healthcare Consulting Services1996 — 1998

Skills & more

Entrepreneurship21Strategy Development2Mergers2Competitive Analysis4Business Planning5Venture Capital43Entrepreneurial SkillsRaising FinancePortfolio Management8Mergers & Acquisitions7Strategy17Business Development12
+7 moreInvestmentsPrivate EquityHealthcareStart-upsCross-functional Team LeadershipLifesciencesLife Sciences

Languages Hebrew

From Adam's professional profile.

Colleagues at Windham Capital Partners

Alistair Erskine
Operating Partner at Windham Capital Partners
Allan Bufferd
Advisor at Windham Capital Partners
Bill Crouse
Advisor at Windham Capital Partners
David Kereiakes
Managing Partner at Windham Capital Partners
Deneen Vojta
Senior Advisor at Windham Capital Partners
Jason Helgerson
Operating Partner at Windham Capital Partners
Jeffrey Sachs
Advisor at Windham Capital Partners
Joe Proto
Co-Founder at Windham Capital Partners

Frequently asked questions

Who is Adam E. Fine?
Co-founder, General Partner and CEO of Windham Capital Partners, currently a board director at RxWare, Neuspera, Andros and Valera. Previously VP & GM at healthcare enterprise software company I-many, and earlier worked at Johnson & Johnson companies Cordis & Biosense and at Coopers & Lybrand.
Where does Adam E. Fine work?
Adam E. Fine is General Partner & CEO at Windham Capital Partners and Board director at Valera Health and Board director at RxWare and Board director at GlySens.
What does Adam E. Fine invest in?
Adam E. Fine invests in Biotech, Deep Tech, Hardware, Healthtech, SaaS.
Where did Adam E. Fine go to school?
Adam E. Fine studied at New York University (MBA, Finance); Boston University (BA, International Relations).

Same school

Also attended New York University385

Jonathan RossFounder of Groq; inventor of Google's TPU — now at NvidiaGabriella GiglioHR & Executive Talent at General CatalystAndrea EchstenkamperVP of Marketing at HeavybitRami BranitzkyPartner at Sapphire VenturesZach WhiteInvestment Team at 8VCAnkita TiwariPrograms Manager at StartX

+ 379 more

Also attended Boston University258

Aydin SenkutFounder & Managing Partner at FelicisVinnie LauriaFounding Partner at Golden Gate VenturesGil GorenPartner at 83NorthJames LindenbaumCo-founder at HeavybitDave BiscegliaVenture Partner at Founder CollectiveKatherine OgnibeneOperations Associate at Founder Collective

+ 252 more

Shared employers

Also worked at andros1

Zack KingVenture Advisor; CEO, Shyft Analytics at Slater Technology Fund

Also worked at NeuSpera Medical Inc.5

Tracy PappasInvestor at Treo Ventures, LlcLori HuManaging Director at Vertex Ventures HCJuan-Pablo MasPartner at Action Potential Venture Capital Ltd.Cynthia YeePartner at Vensana CapitalImran EbaPartner at Action Potential Venture Capital Ltd.

Also worked at Personal Genome Diagnostics1

Abby McElhinnyChief Scientific Officer at AOA Dx

Also worked at Cureatr5

Joseph MayerPartner at HLM Investment PartnersWilliam WinkenwerderChairman & Director, CitiusTech at Empactful CapitalTodd PietriCo-Founder and Managing Partner at Activate Venture PartnersRick BunkerChief Technology and Product Officer at InveniamMomo BiPrincipal at Empire State Development – New York Ventures